Stockscreener 앱 받기
29.36
2.02%
0.58
시장 영업 전:
29.36
Alkermes Plc 주식(ALKS)의 최신 뉴스
How FDA Breakthrough Therapy Status for Alixorexton Will Impact Alkermes (ALKS) Investors - simplywall.st
FDA Grants Breakthrough Therapy Designation to ALKS' Narcolepsy Drug - Finviz
Alkermes plc's (NASDAQ:ALKS) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong? - simplywall.st
Why Analysts See The Alkermes (ALKS) Story Shifting After Avadel Deal And Orexin Data - Yahoo Finance
FDA Grants Alixorexton Breakthrough Therapy Designation for Narcolepsy Type 1 - Sleep Review
Is Alkermes plc (8AK) stock a top pick for value investors2026 world cup usa national team round of 16 goalkeepers set piece tactics knockout prediction expert opinion - ulpravda.ru
Is Alkermes (ALKS) Pricing Reflect Its DCF Value Gap And Recent Mixed Returns - Yahoo Finance
Alkermes to present at the 44th annual JP Morgan Healthcare Conference - MSN
FDA Grants Breakthrough Therapy Designation to Alixorexton for Narcolepsy Type 1 - HCP Live
Alkermes stock rises after FDA grants Breakthrough Therapy status - Investing.com
FDA grants breakthrough therapy status to Alkermes’ narcolepsy drug By Investing.com - Investing.com South Africa
Alkermes Gains FDA Breakthrough Status for Narcolepsy Drug - TipRanks
Alkermes plc Granted Breakthrough Therapy Designation for Alixorexton - TradingView — Track All Markets
Alixorexton Granted Breakthrough Therapy Designation by U.S. FDA for the Treatment of Narcolepsy Type 1 - Business Wire
Alkermes Plc (ALKS) Stock Analysis: Unveiling A 55% Upside Potential For Investors - DirectorsTalk Interviews
Alkermes to Host Conference Call to Discuss Financial Results for Quarter Ended June 30, 2013 - AOL.com
Insider Sell: Craig Hopkinson Sells 4,000 Shares of Alkermes PLC (ALKS) - GuruFocus
Alkermes (NASDAQ:ALKS) EVP Sells $112,000.00 in Stock - MarketBeat
J.P. Morgan Healthcare Conference - marketscreener.com
Alkermes stock rises after FDA grants Breakthrough Therapy status By Investing.com - Investing.com UK
Levels Update: Will Alkermes plc 8AK stock outperform global peersChart Signals & Short-Term Trading Alerts - moha.gov.vn
VIRGINIA RETIREMENT SYSTEMS ET Al Invests $27.04 Million in Alkermes plc $ALKS - MarketBeat
Alkermes to Present at the 44th Annual J.P. Morgan Healthcare Conference - FinancialContent
Centessa narcolepsy data not superior to Alkermes, says Stifel - MSN
Trading the Move, Not the Narrative: (ALKS) Edition - Stock Traders Daily
Alkermes plc $ALKS Shares Sold by Rice Hall James & Associates LLC - MarketBeat
Pacer Advisors Inc. Sells 98,825 Shares of Alkermes plc $ALKS - MarketBeat
About the Alkermes Inspiration Grants® Program - CSRwire
Alkermes plc (ALKS) Stock Price History & Data - Traders Union
Why Analysts are Rating Alkermes (ALKS) a Buy - Finviz
Why analysts are rating Alkermes (ALKS) a buy - MSN
15 Most Promising Mid-Cap Healthcare Stocks Under $50 - Insider Monkey
Alkermes plc (NASDAQ:ALKS) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Is Alkermes plc stock positioned for digital transformation2025 Market Outlook & Weekly Breakout Watchlists - Улправда
Will Alkermes plc stock split attract more investors2025 Earnings Impact & Proven Capital Preservation Tips - Улправда
Will Alkermes plc stock benefit from commodity pricesTrade Analysis Summary & Growth Focused Stock Pick Reports - Улправда
Why global investors buy Alkermes plc (8AK) stockEarnings Recap Report & Reliable Volume Spike Alerts - Bölüm Sonu Canavarı
ALKS (Alkermes) Other Current Payables : $0 Mil (As of Sep. 2025) - GuruFocus
Will Alkermes plc (8AK) stock test record highs in 20252025 Performance Recap & Low Risk Growth Stock Ideas - DonanımHaber
Can Alkermes plc stock continue upward trendPortfolio Gains Summary & Comprehensive Market Scan Reports - DonanımHaber
Bear Alert: Will Alkermes plc stock split attract more investorsOil Prices & Technical Pattern Alert System - ulpravda.ru
Behavioral Patterns of ALKS and Institutional Flows - Stock Traders Daily
Is Alkermes plc (8AK) stock a momentum leaderTrade Risk Assessment & Real-Time Stock Entry Alerts - Улправда
How Alkermes plc (8AK) stock reacts to monetary easingBear Alert & Free Reliable Trade Execution Plans - Улправда
Alkermes (STU:8AK) OCF Margin % : 25.79% (As of Sep. 2025) - GuruFocus
BlackRock increases stake in Alkermes to 17.04% - Investing.com
REGBlackRock GroupSAR 6ALKERMES PLC - TradingView — Track All Markets
Frazier Life Sciences Management L.P. Boosts Stock Position in Alkermes plc $ALKS - MarketBeat
EcoR1 Capital LLC Makes New Investment in Alkermes plc $ALKS - MarketBeat
Retail Surge: Why global investors buy Alkermes plc 8AK stockCEO Change & Expert Curated Trade Ideas - moha.gov.vn
History Review: Will Alkermes plc 8AK stock test record highs in 2025Watch List & High Conviction Investment Ideas - moha.gov.vn
BlackRock increases stake in Alkermes to 17% By Investing.com - Investing.com South Africa
BlackRock increases stake in Alkermes to 17% - Investing.com
4.03%
2.38%
자본화:
|
볼륨(24시간):